Organ infiltration in patients with progressive CLL
| Patient . | Organ . | Asymptomatic disease . | Active disease . |
|---|---|---|---|
| #1 | Spleen | (vi) − | − |
| LN | − | + | |
| #2 | Spleen | − | + |
| LN | − | + | |
| #3 | Spleen | − | + |
| LN | − | + | |
| #4 | Spleen | − | + |
| LN | + | + | |
| #5 | Spleen | − | + |
| LN | + | + |
| Patient . | Organ . | Asymptomatic disease . | Active disease . |
|---|---|---|---|
| #1 | Spleen | (vi) − | − |
| LN | − | + | |
| #2 | Spleen | − | + |
| LN | − | + | |
| #3 | Spleen | − | + |
| LN | − | + | |
| #4 | Spleen | − | + |
| LN | + | + | |
| #5 | Spleen | − | + |
| LN | + | + |
Analyses were performed on 5 CLL patients with asymptomatic disease (asymptomatic) and at a later stage (active) when disease progressed sufficiently to require treatment. Organ infiltration was assessed as reported previously.6
−, undetectable organ infiltration; +, organ infiltration.